Cargando…

Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors

Broadly neutralizing antibodies (bnAbs) to the HIV envelope (Env) V2-apex region are important leads for HIV vaccine design. Most V2-apex bnAbs engage Env with an uncommonly long heavy-chain complementarity-determining region 3 (HCDR3), suggesting that the rarity of bnAb precursors poses a challenge...

Descripción completa

Detalles Bibliográficos
Autores principales: Willis, Jordan R., Berndsen, Zachary T., Ma, Krystal M., Steichen, Jon M., Schiffner, Torben, Landais, Elise, Liguori, Alessia, Kalyuzhniy, Oleksandr, Allen, Joel D., Baboo, Sabyasachi, Omorodion, Oluwarotimi, Diedrich, Jolene K., Hu, Xiaozhen, Georgeson, Erik, Phelps, Nicole, Eskandarzadeh, Saman, Groschel, Bettina, Kubitz, Michael, Adachi, Yumiko, Mullin, Tina-Marie, Alavi, Nushin B., Falcone, Samantha, Himansu, Sunny, Carfi, Andrea, Wilson, Ian A., Yates, John R., Paulson, James C., Crispin, Max, Ward, Andrew B., Schief, William R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cell Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671094/
https://www.ncbi.nlm.nih.gov/pubmed/36179689
http://dx.doi.org/10.1016/j.immuni.2022.09.001
_version_ 1784832468651606016
author Willis, Jordan R.
Berndsen, Zachary T.
Ma, Krystal M.
Steichen, Jon M.
Schiffner, Torben
Landais, Elise
Liguori, Alessia
Kalyuzhniy, Oleksandr
Allen, Joel D.
Baboo, Sabyasachi
Omorodion, Oluwarotimi
Diedrich, Jolene K.
Hu, Xiaozhen
Georgeson, Erik
Phelps, Nicole
Eskandarzadeh, Saman
Groschel, Bettina
Kubitz, Michael
Adachi, Yumiko
Mullin, Tina-Marie
Alavi, Nushin B.
Falcone, Samantha
Himansu, Sunny
Carfi, Andrea
Wilson, Ian A.
Yates, John R.
Paulson, James C.
Crispin, Max
Ward, Andrew B.
Schief, William R.
author_facet Willis, Jordan R.
Berndsen, Zachary T.
Ma, Krystal M.
Steichen, Jon M.
Schiffner, Torben
Landais, Elise
Liguori, Alessia
Kalyuzhniy, Oleksandr
Allen, Joel D.
Baboo, Sabyasachi
Omorodion, Oluwarotimi
Diedrich, Jolene K.
Hu, Xiaozhen
Georgeson, Erik
Phelps, Nicole
Eskandarzadeh, Saman
Groschel, Bettina
Kubitz, Michael
Adachi, Yumiko
Mullin, Tina-Marie
Alavi, Nushin B.
Falcone, Samantha
Himansu, Sunny
Carfi, Andrea
Wilson, Ian A.
Yates, John R.
Paulson, James C.
Crispin, Max
Ward, Andrew B.
Schief, William R.
author_sort Willis, Jordan R.
collection PubMed
description Broadly neutralizing antibodies (bnAbs) to the HIV envelope (Env) V2-apex region are important leads for HIV vaccine design. Most V2-apex bnAbs engage Env with an uncommonly long heavy-chain complementarity-determining region 3 (HCDR3), suggesting that the rarity of bnAb precursors poses a challenge for vaccine priming. We created precursor sequence definitions for V2-apex HCDR3-dependent bnAbs and searched for related precursors in human antibody heavy-chain ultradeep sequencing data from 14 HIV-unexposed donors. We found potential precursors in a majority of donors for only two long-HCDR3 V2-apex bnAbs, PCT64 and PG9, identifying these bnAbs as priority vaccine targets. We then engineered ApexGT Env trimers that bound inferred germlines for PCT64 and PG9 and had higher affinities for bnAbs, determined cryo-EM structures of ApexGT trimers complexed with inferred-germline and bnAb forms of PCT64 and PG9, and developed an mRNA-encoded cell-surface ApexGT trimer. These methods and immunogens have promise to assist HIV vaccine development.
format Online
Article
Text
id pubmed-9671094
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cell Press
record_format MEDLINE/PubMed
spelling pubmed-96710942022-11-18 Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors Willis, Jordan R. Berndsen, Zachary T. Ma, Krystal M. Steichen, Jon M. Schiffner, Torben Landais, Elise Liguori, Alessia Kalyuzhniy, Oleksandr Allen, Joel D. Baboo, Sabyasachi Omorodion, Oluwarotimi Diedrich, Jolene K. Hu, Xiaozhen Georgeson, Erik Phelps, Nicole Eskandarzadeh, Saman Groschel, Bettina Kubitz, Michael Adachi, Yumiko Mullin, Tina-Marie Alavi, Nushin B. Falcone, Samantha Himansu, Sunny Carfi, Andrea Wilson, Ian A. Yates, John R. Paulson, James C. Crispin, Max Ward, Andrew B. Schief, William R. Immunity Article Broadly neutralizing antibodies (bnAbs) to the HIV envelope (Env) V2-apex region are important leads for HIV vaccine design. Most V2-apex bnAbs engage Env with an uncommonly long heavy-chain complementarity-determining region 3 (HCDR3), suggesting that the rarity of bnAb precursors poses a challenge for vaccine priming. We created precursor sequence definitions for V2-apex HCDR3-dependent bnAbs and searched for related precursors in human antibody heavy-chain ultradeep sequencing data from 14 HIV-unexposed donors. We found potential precursors in a majority of donors for only two long-HCDR3 V2-apex bnAbs, PCT64 and PG9, identifying these bnAbs as priority vaccine targets. We then engineered ApexGT Env trimers that bound inferred germlines for PCT64 and PG9 and had higher affinities for bnAbs, determined cryo-EM structures of ApexGT trimers complexed with inferred-germline and bnAb forms of PCT64 and PG9, and developed an mRNA-encoded cell-surface ApexGT trimer. These methods and immunogens have promise to assist HIV vaccine development. Cell Press 2022-11-08 /pmc/articles/PMC9671094/ /pubmed/36179689 http://dx.doi.org/10.1016/j.immuni.2022.09.001 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Willis, Jordan R.
Berndsen, Zachary T.
Ma, Krystal M.
Steichen, Jon M.
Schiffner, Torben
Landais, Elise
Liguori, Alessia
Kalyuzhniy, Oleksandr
Allen, Joel D.
Baboo, Sabyasachi
Omorodion, Oluwarotimi
Diedrich, Jolene K.
Hu, Xiaozhen
Georgeson, Erik
Phelps, Nicole
Eskandarzadeh, Saman
Groschel, Bettina
Kubitz, Michael
Adachi, Yumiko
Mullin, Tina-Marie
Alavi, Nushin B.
Falcone, Samantha
Himansu, Sunny
Carfi, Andrea
Wilson, Ian A.
Yates, John R.
Paulson, James C.
Crispin, Max
Ward, Andrew B.
Schief, William R.
Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors
title Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors
title_full Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors
title_fullStr Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors
title_full_unstemmed Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors
title_short Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors
title_sort human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting hiv v2-apex broadly neutralizing antibody precursors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671094/
https://www.ncbi.nlm.nih.gov/pubmed/36179689
http://dx.doi.org/10.1016/j.immuni.2022.09.001
work_keys_str_mv AT willisjordanr humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors
AT berndsenzacharyt humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors
AT makrystalm humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors
AT steichenjonm humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors
AT schiffnertorben humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors
AT landaiselise humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors
AT liguorialessia humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors
AT kalyuzhniyoleksandr humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors
AT allenjoeld humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors
AT baboosabyasachi humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors
AT omorodionoluwarotimi humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors
AT diedrichjolenek humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors
AT huxiaozhen humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors
AT georgesonerik humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors
AT phelpsnicole humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors
AT eskandarzadehsaman humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors
AT groschelbettina humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors
AT kubitzmichael humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors
AT adachiyumiko humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors
AT mullintinamarie humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors
AT alavinushinb humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors
AT falconesamantha humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors
AT himansusunny humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors
AT carfiandrea humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors
AT wilsoniana humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors
AT yatesjohnr humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors
AT paulsonjamesc humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors
AT crispinmax humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors
AT wardandrewb humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors
AT schiefwilliamr humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors